Drug
Bim23b065
Bim23b065: highest development phase Phase 2, developed by Ipsen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Ipsen
Trials
| Drug | Phase | Indication |
|---|---|---|
| BIM23B065 NCT03045302 | Phase 2 | Acromegaly |
Latest
No recent events.
Follow Bim23b065 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.